For the second consecutive time, Rush Copley’s radiation oncology program has been awarded a three-year accreditation from the American College of Radiology, or ACR. Radiation oncology, or radiation therapy, is the use of high-energy radiation to treat cancer.
“Rush Copley offers the most advanced radiation therapies, including stereotactic body radiation therapy and high-dose rate brachytherapy, which allow us to target specific areas while minimizing risk to healthy tissue,” says Sea Chen, MD, radiation oncologist and medical director of radiation oncology at Rush Copley. “We are proud that we continue to be recognized as a facility providing the highest quality care and treatment to our patients.”
The ACR accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific guidelines and standards after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field. The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body, with more than 700 accredited sites.
Radiation therapies offered at Rush Copley include traditional 3-D conformal treatment, partial breast irradiation (PBI), intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), high-dose rate (HDR) and low-dose rate (LDR) brachytherapy, stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), respiratory gating system and volumetric modulated arc therapy (VMAT).
